Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Huaheng Biotechnology is a leading Chinese synthetic biology and industrial biotech manufacturer specializing in amino acids, vitamins, probiotics, herbal extracts, and other bio-based products. Its products serve the food industry, animal nutrition sector, daily chemical care/cosmetics market, functional foods/nutritionals sector as well as plant/agricultural nutrition. The company has demonstrated strong financial growth with revenues exceeding ¥1.2 billion (~$180 million USD) in 2023 and robust international expansion[5][7]. It invests heavily in R&D (~10% of revenue), holds ISO 9001/HACCP certifications for quality management[5], and has recently expanded strategic partnerships with global leaders such as BASF to co-develop biostimulant solutions for sustainable agriculture[9].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Huaheng Biotechnology.